TVM Life Science Management GmbH | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55328	Articles
62458	Press releases

Headlines Articles Press releases TVM Life Science Management GmbH

Home
Companies
TVM Life Science Management GmbH

BRIEF

published on 10/30/2024 at 14:05, 21 days 23 hours ago

TVM Unveils AI-Centric Sessions for Biopharma at BIO-Europe 2024

Drug Discovery Healthcare Innovation Medical Diagnostics BIO-Europe 2024 AI In Biopharma
PRESS RELEASE

published on 10/30/2024 at 14:00, 21 days 23 hours ago

DISCOVER THE POWER OF AI IN BIOPHARMA: TVM TO HOST THOUGHT-PROVOKING SESSIONS AT BIO-EUROPE 2024
TVM Capital Life Science to highlight AI's impact on biopharma at BIO-Europe 2024, featuring sessions on drug discovery, diagnostics, and more with industry experts

Drug Discovery AI TVM Capital Life Science Biopharma BIO-Europe 2024
BRIEF

published on 09/11/2024 at 14:05, 2 months 9 days ago

TVM Capital Life Science to Participate in LSI Europe ’24 Emerging Medtech Summit 2024

Investment Strategy Healthcare Innovation Venture Capital Medtech Summit TVM Capital
PRESS RELEASE

published on 09/11/2024 at 14:00, 2 months 9 days ago

TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI EUROPE ’24 EMERGING MEDTECH SUMMIT 2024
TVM Capital Life Science to participate in LSI Europe '24 Emerging Medtech Summit 2024, showcasing partnerships and trends in healthcare technology. Key panel discussion on cross-border investors in medtech

Healthcare Technology Investment TVM Capital Life Science Medtech Summit LSI Europe '24
BRIEF

published on 04/22/2024 at 08:05, 6 months 29 days ago

TVM Capital Life Science Leads €23 Million Funding for Smart Reporting

Healthcare Technology Venture Capital AI In Healthcare Series C Funding Medical Reporting
PRESS RELEASE

published on 04/22/2024 at 08:00, 6 months 29 days ago

TVM CAPITAL LIFE SCIENCE LEADS €23 MILLION SERIES C FINANCING ROUND FOR MEDICAL REPORTING TECHNOLOGY PIONEER, SMART REPORTING
TVM Capital Life Science leads €23 million Series C financing round for medical reporting technology pioneer, Smart Reporting, to expand international partnerships and product development

Series C Financing TVM Capital Life Science Smart Reporting Medical Reporting Technology Radiology And Pathology
BRIEF

published on 03/13/2024 at 15:05, 8 months 7 days ago

TVM Capital Life Science Joins LSI USA '24 Emerging Medtech Summit

Investment Strategy Healthcare Innovation TVM Capital Life Science Medtech Summit Emerging Trends
PRESS RELEASE

published on 03/13/2024 at 15:00, 8 months 7 days ago

TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024
TVM Capital Life Science to participate in LSI USA '24 Emerging Medtech Summit 2024, showcasing industry trends & partnerships. Dr. Luc Marengère & Dr. Sascha Berger to speak on medtech innovation & AI adoption

AI Adoption TVM Capital Life Science LSI USA '24 Emerging Medtech Summit Medical Technologies
PRESS RELEASE

published on 02/06/2024 at 10:10, 9 months 15 days ago

TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE. TVM Capital Life Science announces a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology

Series A Financing TVM Capital Life Science Vektor Medical Arrhythmia Care AI-based Analysis
PRESS RELEASE

published on 01/31/2024 at 10:00, 9 months 21 days ago

TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP
TVM Capital Life Science invests €8 million in Myosotis GmbH to revolutionize elderly care with innovative app, strengthening healthcare communication and administrative processes in care homes

Investment TVM Capital Life Science Myosotis GmbH Innovative App Elderly Care

Accesswire

Published on 11/21/2024 at 13:00, 30 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 30 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 30 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 30 minutes ago

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 30 minutes ago

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 15 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 55 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 15 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 23 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 30 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 10 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 45 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 45 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE